Benzinga | Jun 28, 2021 07:59AM EDT

Maxim Group Initiates Coverage On Mind Medicine with Buy Rating, Announces Price Target of $6

Maxim Group analyst Jason McCarthy initiates coverage on Mind Medicine (NASDAQ:MNMD) with a Buy rating and announces Price Target of $6.